Transfusion Medicine And Hemotherapy impact factor, indexing, ranking (2022)

---

Aim and Scope

Transfusion Medicine And Hemotherapy is a research journal that publishes research related to Hematology. This journal is published by the Karger. The P-ISSN of this journal is 16603796.

Also, check the other important details below like Publisher, ISSN, Ranking, Indexing, Impact Factor (if applicable), Publication fee (APC), Review Time, and Acceptance Rate of Transfusion Medicine and Hemotherapy.

Transfusion Medicine And Hemotherapy Ranking

The Impact Factor of Transfusion Medicine And Hemotherapy is 4.04.

The impact factor (IF) is a measure of the frequency with which the average article in a journal has been cited in a particular year. It is used to measure the importance or rank of a journal by calculating the times its articles are cited.

The impact factor was devised by Eugene Garfield, the founder of the Institute for Scientific Information (ISI) in Philadelphia. Impact factors began to be calculated yearly starting from 1975 for journals listed in the Journal Citation Reports (JCR). ISI was acquired by Thomson Scientific & Healthcare in 1992, and became known as Thomson ISI. In 2018, Thomson-Reuters spun off and sold ISI to Onex Corporation and Baring Private Equity Asia. They founded a new corporation, Clarivate, which is now the publisher of the JCR.

Important Metrics

Journal Title:	Transfusion Medicine and Hemotherapy
Publisher:	Karger
P-ISSN:	16603796
Open Access:	NO
Subject:	Hematology
Citescore:	4.6
SNIP:	1.397
SJR:	0.971
Quartile:	2

Transfusion Medicine and Hemotherapy Indexing

The Transfusion Medicine and Hemotherapy is indexed in:

• UGC CARE
• Scopus
• Web of Science (SCIE)
• DOAJ
• PubMed

An indexed journal means that the journal has gone through and passed a review process of certain requirements done by a journal indexer.

The Web of Science Core Collection includes the Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts & Humanities Citation Index (AHCI), and Emerging Sources Citation Index (ESCI).

Transfusion Medicine And Hemotherapy Impact Factor 2022

The latest impact factor of Transfusion Medicine and Hemotherapy is 4.04.

The impact factor (IF) is a measure of the frequency with which the average article in a journal has been cited in a particular year. It is used to measure the importance or rank of a journal by calculating the times it's articles are cited.

Transfusion Medicine And Hemotherapy Quartile

The latest Quartile of Transfusion Medicine and Hemotherapy is Q2.

Each subject category of journals is divided into four quartiles: Q1, Q2, Q3, Q4. Q1 is occupied by the top 25% of journals in the list; Q2 is occupied by journals in the 25 to 50% group; Q3 is occupied by journals in the 50 to 75% group and Q4 is occupied by journals in the 75 to 100% group.

Publication fee

According to journal website, the publication fee of Transfusion Medicine and Hemotherapy is around 1530 CHF; 1670 USD; 1425 EUR.

An article processing charge (APC), also known as a publication fee, is a fee which is sometimes charged to authors. Most commonly, it is involved in making a work available as open access (OA), in either a full OA journal or in a hybrid journal.

Call for Papers

Visit to the official website of the journal/ conference to check the details about call for papers.

How to publish in Transfusion Medicine And Hemotherapy?

This journal covers the fields/ categories related to Hematology. If your research field is related to Hematology, then visit the official website of Transfusion Medicine and Hemotherapy and send your manuscript.

Tips for publishing in Transfusion Medicine And Hemotherapy:

• Selection of research problem.
• Presenting a solution.
• Designing the paper.
• Make your manuscript publication worthy.
• Write an effective results section.
• Mind your references.

Acceptance Rate

Acceptance rate is the ratio of the number of articles submitted to the number of articles published. Researchers can check the acceptance rate on the journal website. Even you can Contact the editor of the journal.

Journal Publication Time

According to the journal website, the Transfusion Medicine and Hemotherapy publishes research articles in 21 weeks on an average.

Final Summary

Sources:

https://www.scopus.com/sourceid/20187

---